MarketInOut Stock Screener Log In | Sign Up
 

Ligand Pharmaceuticals Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 08/13/2026 10:39
Ligand Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization5,756.41 mln
Float19.24 mln
Earnings Date11/05/2026

EPS

9.71
Strong

P / E

29.75
Elevated

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-3.59
Highly reliable

1-Year Forecast

344
Attractive

Relative Strength

17 / 100
Significantly lagging

Business Description

Ligand Pharmaceuticals is a Florida-based biopharmaceutical company founded in 1987 that builds revenue by licensing a broad portfolio of drug assets to partners around the world rather than selling medicines directly to patients. Its portfolio spans a wide range of medical needs, including cancer, infectious disease, bone health, diabetes, and rare conditions, with partner products already approved and generating royalties alongside a pipeline of drugs still in development. This business model allows Ligand to earn income from multiple revenue streams while sharing the costs and risks of bringing new treatments to market.

Key Fundamentals

EPS9.71
P/E29.75
ROE20.71
RPS14.00
ROIC11.18
ROA12.80
Interest Cover22.53
EBITDA, mln259
EV / EBITDA21.35
EV / EBIT24.43
Revenue, mln291
EV / Revenue19.05

Financial Strength

Altman Z-Score8.53
Piotroski F-Score 6 / 9
Beneish M-Score-3.59
Price to Graham Number4.10
1-Year Target Price344
Shiller PE Ratio51.98
Short Ratio6.00
Short % of Float13.06

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.61% 13 / 100   
1 Month -2.35% 27 / 100   
2 Months 24.4% 89 / 100   
6 Months 55.57% 92 / 100   
1 Year 89.46% 91 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us